Format

Send to

Choose Destination
Can Respir J. 2017;2017:9015914. doi: 10.1155/2017/9015914. Epub 2017 Jun 7.

Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis.

Author information

1
Catalan Health Institute (ICS), Division of Primary Health Care, Department of Health, Barcelona, Catalonia, Spain.
2
Primary Care Research Institute (IDIAP Jordi Gol) and Research Associate, Autonomous University of Barcelona (UAB), Cerdanyola del Vallès, Spain.
3
Catalan Institute for Medical Evaluation (ICAM), Barcelona, Catalonia, Spain.
4
Pneumology Unit, Hospitals de Girona i Salt, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Catalonia, Spain.
5
Ciber de Enfermedades Respiratorias (CIBERES), Palma de Mallorca, Baleares, Spain.
6
Palliative Care Unit, Parc Taulí Hospital, Barcelona, Spain.
7
Department of Public Health, University of Barcelona (UB), Barcelona, Spain.
8
Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA.

Abstract

BACKGROUND:

The mortality from all malignant and nonmalignant asbestos-related diseases remains unknown. The authors assessed the incidence and risk factors for all asbestos-related deaths.

METHODS:

The sample included 544 patients from an asbestos-exposed community in the area of Barcelona (Spain), between Jan 1, 1970, and Dec 31, 2006. Competing risk regression through a subdistribution hazard analysis was used to estimate risk factors for the outcomes.

RESULTS:

Asbestos-related deaths were observed in 167 (30.7%) patients and 57.5% of these deaths were caused by some type of mesothelioma. The incidence rate after diagnosis was 3,600 per 100,000 person-years. In 7.5% of patients death was non-asbestos-related, while pleural and peritoneal mesothelioma were identified in 87 (16.0%) and 18 (3.3%) patients, respectively.

CONCLUSIONS:

Age, sex, household exposure, cumulative nonmalignant asbestos-related disease, and single malignant pathology were identified as risk factors for asbestos-related death. These findings suggest the need to develop a preventive approach to the community and to improve the clinical follow-up process of these patients.

PMID:
28680295
PMCID:
PMC5478817
DOI:
10.1155/2017/9015914
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center